
Protenus (Bluesight)
AI healthcare compliance platform detecting drug diversion, privacy breaches, and insider threats in hospital systems.
What it does
Protenus (now Bluesight) is an AI-native healthcare compliance platform that monitors electronic health records and pharmacy dispensing systems to detect drug diversion, patient privacy breaches, and inappropriate EHR access. AI capabilities include ML behavioral analytics that model normal access patterns for each healthcare worker and flag statistically anomalous EHR access suggesting snooping or diversion, AI drug diversion detection that identifies patterns in controlled substance dispensing, administration, and waste records indicating employee diversion, intelligent case prioritization that scores compliance alerts by severity and likelihood of violation, automated investigation support that gathers relevant audit trail evidence, and compliance analytics that surface systemic risk patterns across departments and roles.
Why AI-NATIVE
Protenus (Bluesight) is AI-native - ML behavioral analytics that detect healthcare compliance violations from normal access pattern deviations are the core product architecture.
Best for
Hospitals, health systems, and healthcare organizations use Bluesight for AI compliance monitoring - ML detecting drug diversion and privacy breaches that manual audit sampling cannot identify across high patient interaction volumes.
Limitations
Bluesight is purpose-built for healthcare EHR and pharmacy compliance — other industries with insider threat concerns use different behavioral analytics platforms.
Bluesight surfaces compliance anomalies but formal investigations must be conducted by compliance officers, HR professionals, and legal counsel — AI identifies risk but humans conduct investigations and make employment decisions.
Healthcare compliance monitoring must balance detection sensitivity against false positives that wrongly implicate employees — organizations must tune thresholds carefully and ensure thorough investigation before taking action on AI-flagged cases.
Alternatives by segment
Bluesight enterprise contracts based on hospital size and bed count. Not published. Annual contracts.





